At PharmACT, our mission is to improve the health of those we serve. We are committed to provide quality, convenient, cost-effective, and accessible solutions that always exceed patients and healthcare practitioners‘ expectations.
GET THE RIGHT TREATMENT, AT THE RIGHT TIME, EVERY TIME
In 2014, the Berlin-based pharmaceutical company Pharmact AG has been established. Our mission is summarized in one sentence: “Therapy for life”.
As the first product group became available, we transferred the commercial activities into our distribution activities team.
Pharmact BioScience GmbH is developing technologies and immunoassays to address today’s major medical challenges such as myocardial infarction, diabetes mellitus and severe liver diseases as well as various compounds for therapeutic purposes. Our core values are innovation, excellence, integrity and safety.
IVD – POINT-of-CARE-TEST
First, we have developed and launched three rapid tests (IVD) which will support our project on arteriosclerosis therapy. These point-of-care tests are the initial results of Pharmact AG’s multinational team.
Our tests for diagnosing a developing type 2 diabetes or liver diseases at an early stage enable rapid diagnostics of the two organs pancreas and liver.
Even mild hepatic diseases such as fatty liver play a key role in fat metabolism and cause poor blood fat values. This, in turn, is an increased risk of vascular calcification (arteriosclerosis).